| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO and Interim CEO
1 company
Smith Hunter C serves as a Chief Financial Officer at RYTM. Across recent SEC filings that breaks down to 0 buys and 51 sells. Those positions are worth an estimated $2.9M at current prices.
Historically, Smith Hunter C's trades have earned a below-average insider score of 38/100 across 25 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -61.6%.
The biggest single holding is RYTM (~$2.9M) as Chief Financial Officer. The recent filings there lean toward selling, a net 263,504 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2022 | RYTM Rhythm Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 833 | $6.10 | $5,081.30 | -2.0% | -52.6% | +288.2% |